| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 29.09. | Exousia Pro, Inc.: Exousia Pro Announces Groundbreaking Study to Revolutionize the Global Edibles Market with CBD-Loaded Exosomes | 238 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / September 29, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based therapies, today announced its plan... ► Artikel lesen | |
| 26.09. | Exousia Pro, Inc.: Exousia Pro Reports Positive Outcome in Legal Proceeding | 262 | ACCESS Newswire | Focused on Protecting Shareholder Value and Advancing Core Business ORLANDO, FLORIDA / ACCESS Newswire / September 26, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company... ► Artikel lesen | |
| 10.09. | Exousia Pro, Inc.: Exousia Pro Files Provisional Patent for Novel Extracellular Vesicle Loading Method, Tapping into Multi-Billion Dollar Markets | 236 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / September 10, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotechnology company and innovator in exosome-based therapies, today announced a key strategic... ► Artikel lesen | |
| 08.09. | Exousia Pro, Inc.: Exousia Pro Announces Strategic Acquisition to Launch a New Telehealth Division | 306 | ACCESS Newswire | Exousia Health is expected to have an initial patient base of 1,000 active clients, projected to generate approximately $50,000 in monthly revenue. ORLANDO, FL / ACCESS Newswire / September 8, 2025... ► Artikel lesen | |
| 03.09. | Exousia Pro, Inc.: Exousia Pro Creates New Subdivisions | 278 | ACCESS Newswire | Exousia Pro aims to develop three new subdivisions and launch new products during the 4th quarter.The market for our new products is currently valued at $8.7 billion, projected to grow to $18.5 billion... ► Artikel lesen | |
| EXOUSIA Aktie jetzt für 0€ handeln | |||||
| 25.06. | Marijuana Inc.: Exousia Pro Files Reg A. | 241 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / June 25, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), Exousia Pro, Inc., a clinical-stage biotech company utilizing exosomes in therapies helpful in the treatment of... ► Artikel lesen | |
| 18.06. | Marijuana Inc.: Exousia Pro Expands its Scientific Advisory Board | 546 | ACCESS Newswire | Dr. Marvin S. Hausman, MD, will be Chairman of the Scientific Advisory Board. ORLANDO, FLORIDA / ACCESS Newswire / June 18, 2025 / Exousia Pro, Inc. (OTCPINK:MAJI), a clinical-stage biotech company... ► Artikel lesen | |
| 30.04. | Marijuana Inc.: Exousia Pro Will Launch a Web Series with Our New Consultant | 282 | ACCESS Newswire | Dr. Marvin Hausman is joining Exousia Pro as a Consultant and will host a weekly series. ORLANDO, FL / ACCESS Newswire / April 30, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, Inc., a clinical-stage... ► Artikel lesen | |
| 29.04. | Marijuana Inc.: Exousia Pro Finishes Preclinical Trial for Glioblastoma Ahead of Schedule - Bolstering Orphan Drug Application | 301 | ACCESS Newswire | - Rigorous humanized mouse model enhances credibility and translatability of results- Key preclinical data to support FDA Orphan Drug Application- In vitro success signals potential for exosome-based... ► Artikel lesen | |
| 21.04. | Marijuana Inc.: Exousia Pro CSO Revealed Significant Findings About the Glioblastoma Study in a Spaces Interview | 361 | ACCESS Newswire | A published paper shows NANOG Expression was almost 100% effective at eradicating tumor cells ORLANDO, FL / ACCESS Newswire / April 21, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc.,... ► Artikel lesen | |
| 17.04. | Marijuana Inc.: Exousia Pro Offers Guidance on New Subdivisions | 350 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / April 17, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, a clinical-stage biotech company utilizing exosomes in the treatment of cancer and other diseases, is... ► Artikel lesen | |
| 08.04. | Marijuana Inc.: Exousia Pro to Deliver 500 Billion Dried Exosomes for Trade Show | 395 | ACCESS Newswire | Exousia Pro has a 60% margin built-in on each order of exosomes ORLANDO, FLORIDA / ACCESS Newswire / April 8, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company... ► Artikel lesen | |
| 03.04. | Marijuana Inc.: Exousia Pro Issues Update on Name Change | 261 | ACCESS Newswire | ORLANDO, FLORIDA / ACCESS Newswire / April 3, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company utilizing exosomes in the treatment of cancer and other diseases... ► Artikel lesen | |
| 02.04. | Marijuana Inc.: Exousia Pro Has Appointed Matthew Dwyer As Its New President | 346 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / April 2, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company using exosomes in the treatment of cancer and other maladies,... ► Artikel lesen | |
| 01.04. | Marijuana Inc.: Exousia Pro Issues and Update on its FDA Orphan Drug Status | 367 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / April 1, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company using exosomes in the treatment of cancer and other maladies,... ► Artikel lesen | |
| 25.03. | Marijuana Inc.: Exousia Pro Officially Announces the Production of Plant-Based Exosomes Has Begun | 794 | ACCESS Newswire | Exousia Pro will be sending out samples to clients expected to place orders ORLANDO, FL / ACCESS Newswire / March 25, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., announces the official... ► Artikel lesen | |
| 18.03. | Marijuana Inc.: Exousia Has Successfully Renegotiated Its License Agreement | 422 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / March 18, 2025 / MARIJUANA INC. (OTCPINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company using exosomes in the treatment of cancer and other maladies,... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SARTORIUS AG VZ | 241,40 | +1,09 % | Sartorius-Konkurrent mit Ärger: Enttäuschende Zahlen: Dieser Dividendenwachstumswert gerät jetzt unter Druck! | © Foto: MidjourneyDer bei wachstumsorientierten Dividendenanlegern beliebte Life-Science-Wert Abbott Laboratories kann mit seinen Zahlen zum dritten Quartal nicht überzeugen. Abbott Laboratories: Langfristig... ► Artikel lesen | |
| SERVE ROBOTICS | 14,220 | 0,00 % | Serve Robotics Inc.: DoorDash and Serve Robotics Partner to Bring Serve's Delivery Robots to the DoorDash Platform | SAN FRANCISCO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- DoorDash (Nasdaq: DASH), a leading local commerce platform globally, and Serve Robotics Inc. (Nasdaq: SERV), a leading autonomous sidewalk delivery... ► Artikel lesen | |
| DRONESHIELD | 2,675 | -2,55 % | Droneshield-Aktie nach Höhenflug: Jetzt einsteigen oder ist das der Griff ins fallende Messer? | Die DroneShield-Aktie hat bereits um rund 25% an Wert verloren - alles nur Gewinnmitnahmen oder fundamentale Zweifel? Wie weiter? Trotz beeindruckender Kursgewinne und technischer Durchbrüche mehren... ► Artikel lesen | |
| BYRNA TECHNOLOGIES | 20,740 | 0,00 % | Byrna Technologies, Inc.: Byrna Technologies Announces Preliminary Fiscal Second Quarter Record Revenues of $28.5 Million | ANDOVER, Mass., June 05, 2025 (GLOBE NEWSWIRE) -- Byrna Technologies Inc. ("Byrna" or the "Company") (Nasdaq: BYRN), a technology company, specializing in the development, manufacture, and sale of... ► Artikel lesen | |
| EVOLV TECHNOLOGIES | 8,005 | 0,00 % | Evolv Technology releases updated security screening software | ||
| KRATOS DEFENSE | 77,00 | -1,43 % | Kratos: Der Aufstieg zum Radar-Champion | Die geopolitischen Spannungen treiben derzeit das globale Aufrüsten weiter an. Besonders gefragt sind fortschrittliche Radarsysteme, wovon Kratos Defense & Security Solutions stark profitiert. Das TSI-USA-System... ► Artikel lesen | |
| HUDSON TECHNOLOGIES | 9,000 | 0,00 % | Hudson Technologies to Host Climate Week NYC 2025 Panel Discussion "Reclaiming the Future Together" | ||
| PVA TEPLA | 29,980 | -1,96 % | JEFFERIES stuft PVA TEPLA AG auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für PVA Tepla von 33 auf 37 Euro angehoben und die Einstufung auf "Buy" belassen. Die anstehenden Zahlen des Technologiekonzerns... ► Artikel lesen | |
| 2G ENERGY | 32,900 | -0,15 % | Interview 2G Energy AG: "Das beherrschende Thema in den USA ist Strom, Strom, Strom" | ||
| UNUSUAL MACHINES | 12,500 | 0,00 % | Unusual Machines, Inc.: Unusual Machines Appoints Jason Reels as Vice President of Supply Chain | Reels to strengthen operational execution and expand U.S.-based manufacturing capacity for defense and enterprise markets ORLANDO, FLORIDA / ACCESS Newswire / October 20, 2025 / Unusual Machines (NYSE... ► Artikel lesen | |
| INNOVATIVE SOLUTIONS & SUPPORT | 11,480 | 0,00 % | IS&S Rebrands to Innovative Aerosystems | New brand identity reflects focus on integrating advanced avionics with intelligent system designs to deliver innovative aerospace solutions
EXTON, Pa.--(BUSINESS WIRE)--Innovative Solutions & Support... ► Artikel lesen | |
| GEOSPACE TECHNOLOGIES | 23,910 | +5,89 % | GEOSPACE TECHNOLOGIES CORP - 8-K, Current Report | ||
| ACCURAY | 1,290 | -6,52 % | ACCURAY INC - 8-K, Current Report | ||
| INTELLEGO TECHNOLOGIES | 9,220 | +7,08 % | Intellego Technologies AB: Intellego Technologies appoints Henrik Resmark as new COO | Intellego Technologies AB (publ) ("Intellego") has today appointed Henrik Resmark as its new Chief Operating Officer (COO) and member of the executive management team, effective January 2, 2026.
Henrik... ► Artikel lesen | |
| AXON ENTERPRISE | 609,60 | +0,07 % | Axon Enterprise, Inc. (AXON): A Bull Case Theory |